Wanting Qiang - Myeloma & Lymphoma Center, Shanghai Changzheng Hospital

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 39 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Genomic Characteristics and Prognostic Correlations in Chinese Multiple Myeloma Patients

Xi Chen, Tianchen Luo, Wenhui Zhang, Sheng Wang, Mengxuan Zhu,Haiyan He,Jin Liu,Jing Lu,Wanting Qiang,Yanchun Jia,Nan Hou, Xuenan Zhao, Shan Zhang,Jing Li,Juan Du

BMC Medical Genomicsno. 1 (2025): 1-14

引用0浏览0WOS引用

Lowering the Selinexor Dose Within the Pomalidomide and Dexamethasone Combination Regimen Elicits Fewer Side Effects While Comparable Efficacy Against Relapsed/Refractory Multiple Myeloma

Liying Peng, Tiantian Shan,Xinyi Zhou, Zhongyuan Feng,Wanting Qiang,Jing Lu,Haiyan He,Juan Du

OncoTargets and therapy (2025): 695-703

引用0浏览0WOS引用

A Five-Year Follow-Up Clinical Study of the B Cell Maturation Antigen Chimeric Antigen Receptor-T Cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma

Dongjian Chen, Yu Zhu,Zhi Chen,Songfu Jiang,Haiyan He,Wanting Qiang,Fang Xiang,Xuedong Sun,Juan Du

Clinical Cancer Research (2024)

引用0浏览0引用

[BCMA Chimeric Antigen Receptor T Cells Therapy Re-Treatment of a Patient with Recurrent/refractory IgD Multiple Myeloma: A Case Report and Literature Review]

S N Gu,W T Qiang, J Lu,Z Y Feng, J Du

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhino. 10 (2024): 951-955

引用0浏览0WOS引用

Autologous B Cell Maturation Antigen (BCMA) and CD19 Dual Targeting Fastcar-T Cells (GC012F/AZD0120) As First-Line Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma Patients

Juan Du,Wanting Qiang,Jing Lu,Yanchun Jia,Haiyan He, Jin Liu,Pei Guo,Ying Yang,Zhongyuan Feng,Lina Jin, Xiaoqiang Fan, Nina Shah, Qi Zhang,Jia Liu,Lihong Weng,Lianjun Shen, Wei Cao

Bloodno. Supplement 1 (2024): 2072-2072

引用0浏览0引用

A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma

Dongjian Chen, Yu Zhu,Zhi Chen,Songfu Jiang,Haiyan He,Wanting Qiang,Fang Xiang,Xuedong Sun,Juan Du

CLINICAL CANCER RESEARCHno. 17 (2024): 3747-3756

引用0浏览0WOS引用

An Open-Label, Prospective Trial to Evaluate the Efficacy and Safety of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Patients with Newly Diagnosed POEMS Syndrome

Haiyan He,Nan Hou, Xi Chen, Yaqi Song,Wanting Qiang, Jin Liu, Jing Lu,Weijun Fu,Juan Du

British Journal of Haematology（2024）

引用1浏览0WOS引用

Supplementary Data 1 from A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma

Dongjian Chen, Yu Zhu, Zhi Chen,Songfu Jiang,Haiyan He,Wanting Qiang,Fang Xiang,Xuedong Sun,Juan Du

crossref（2024）

引用0浏览0引用

B-Cell Maturation Antigen/CD19 Dual-Targeting Immunotherapy in Newly Diagnosed Multiple Myeloma

Wanting Qiang,Jing Lu,Yanchun Jia,Jia Liu, Jin Liu,Haiyan He, Xiaoxiang Wang, Xiaoqiang Fan,Lina Jin, Qianqi Ruan, Qi Zhang,Lianjun Shen,Lihong Weng, Wei Cao, Wenling Li,Juan Du

JAMA Oncology (2024)

引用1浏览0WOS引用

P926: ELEVATED SERUM LEVELS OF SOLUBLE B-CELL MATURATION ANTIGEN AS A PROGNOSTIC BIOMARKER FOR MULTIPLE MYELOMA

Juan Du,Pei Guo, Yun Wang,Haiyan He,Dongjian Chen,Jin Liu,Wanting Qiang,Jing Lu,Yang Liang

HemaSphereno. S3 (2023)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn